Archive » Medical Ultrasonography, September 2009, volume 11, number 3 » Continuing Education » The role of contrast-enhanced ultrasonography with second generation contrast agents in the evaluation of focal splenic lesions
(490 KB, PDF file)
Abstract
Abdominal ultrasound is the method of choice for fi rst line evaluation of the spleen, allowing not only organ measurement and splenomegaly assessment, but it also detects possible focal lesions. But standard US is not able to answer an important question: whether the focal lesion is benign or malignant. Contrast enhanced ultrasound (CEUS) with second generation contrast agents (SonoVue) primary allows the characterization of vascular pattern in focal lesions, its fi rst indication being focal liver lesions assessment. The method is studied also for the spleen, in which CEUS allows the description of different focal lesions. There are 2 main indications for CEUS spleen assessment. First in trauma patients in which standard US was performed and possible spleen lesions or peritoneal liquid were found; or clinical or laboratory signs indicating a possible spleen lesion are present (EFSUMB guidelines). These indications are not discussed in this particular article. The second is for characterization of focal spleen lesions discovered by standard US, as well as for the follow up of patients with malignant hematological disorders. Available published data confi rm that CEUS examination using second generation contrast agents is a promising method also for the characterization of splenic lesions.